Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Tirzepatide stands out among GLP-1 receptor agonists due to its dual action on both GIP and GLP-1 receptors, enhancing weight loss and blood sugar control compared to those that target only GLP-1
If it has been more than a week, restart the previous tolerated dose rather than escalating
Current guidelines from the American Society for Metabolic and Bariatric Surgery (ASMBS) recommend offering surgery to patients with BMI 35 kg/m regardless of comorbidities, and considering it for those with BMI 30-34.9 kg/m with metabolic disease, though insurance coverage criteria may vary
Once treatment begins, youll receive regular support to ensure your success
Your provider will guide you to the best plan based on your goals
US$ 29.60
US$ 26.50
US$ 20.97
